Company

Poolbeg Pharma plc

Biotechnology Research London, City of, United Kingdom 15 employees AIM

Employees: 15
Contacts: 2
Emails: 2
Phones: 1

www.poolbegpharma.com LinkedIn Crunchbase

Poolbeg Pharma plc Overview

Headquarters: London, City of, United Kingdom
Website: www.poolbegpharma.com
Industry: Biotechnology Research
Employees: 15
Founded: 2021
Stock Symbol: AIM
Funding: 5.6M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

cancer immunotherapy oncology GLP-1 agonist obesity RSV influenza Oral GLP-1 metabolic conditions Artificial Intelligence AI

About Poolbeg Pharma plc

Poolbeg Pharma plc is a clinical-stage biopharmaceutical company focussed on the development of innovative medicines to address unmet medical needs. The Company’s clinical programmes target large addressable markets including, cancer immunotherapy-induced Cytokine Release Syndrome (“CRS”) and metabolic conditions such as obesity with the development of an oral encapsulated glucagon-like peptide GLP-1R agonist. Ticker AIM: POLB

Poolbeg Pharma plc Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Poolbeg Pharma plc Org Chart

Sample employees and titles

Name	Title	Location	Contact
Brendan Buckley	Chief Medical Officer at Teckro		View
Cathal Friel	Dublin, London & Vienna, Chairman and Co-founder at Open Orphan Plc (Now Hvivo Plc) & Poolbeg Pharma Plc, Co-founder & Director at Euro Green	Greater Dublin, Ireland	Email Phone
Eddie Gibson	Associate at Wickenstones Ltd		View
Jeremy Skillington, Phd	Chief Executive Officer at Poolbeg Pharma	Ireland	Email